Humana Denied Cancer Treatment: Your Appeal Rights

Receiving a cancer treatment denial from Humana is devastating. Humana covers millions of members through commercial plans, Medicare Advantage, and Medicaid managed care, and its oncology denials span chemotherapy, immunotherapy, targeted therapy, radiation, and surgical procedures. Cancer treatment appeals have some of the highest reversal rates of any denial category — but only when the right evidence is assembled and submitted correctly.

Why Humana Denies Cancer Treatment Claims

• Medical necessity disputes — Humana denies cancer treatments when its clinical reviewers determine the prescribed treatment does not meet their internal criteria — frequently when the oncologist recommends a regimen that Humana's policy classifies as second-line for the cancer staging or molecular profile documented in the file, or when Humana's reviewer disagrees with the treating oncologist's staging interpretation
• Experimental or investigational classification — Humana classifies certain treatments as experimental, particularly newer immunotherapy agents, targeted therapies for rare molecular subtypes, and off-label regimens — even when the oncologist has strong clinical reasons and NCCN guidelines support the treatment
• Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization denials and delays — Humana requires prior authorization for virtually all cancer treatments; reviewers may deny based on incomplete documentation, disagreement with the treatment plan, or proprietary clinical criteria; for cancer patients, these delays can mean weeks without treatment during a critical window
• Step therapy and fail-first protocols — Humana may require patients to try and fail on a less expensive first-line regimen before authorizing the oncologist's recommendation; in oncology, step therapy delays effective treatment, allows disease progression, and exposes patients to unnecessary toxicity
• Medicare Advantage overreach — Despite being required to cover everything Original Medicare covers, Humana applies utilization management tools that Original Medicare does not; federal investigations have documented that Humana MA denies services that would be covered under Original Medicare

How to Appeal Humana's Cancer Treatment Denial

Step 1: Request Expedited Processing Immediately

Under ACA Section 2719 (42 U.S.C. § 18001) and CMS regulations for Medicare Advantage, Humana must respond to expedited pre-service appeals within 72 hours when delay would jeopardize the patient's life or health. File by phone and in writing simultaneously. Call 1-800-444-9100 (commercial) or 1-800-457-4708 (Medicare Advantage). State clearly: "I am requesting expedited processing because delay of this cancer treatment would seriously jeopardize [patient]'s life or health."

Step 2: Obtain NCCN Guideline Support With Molecular Specificity

Your oncologist's documentation must include: complete cancer diagnosis with staging, histology, and molecular markers (ER/PR, HER2, PD-L1 expression, EGFR mutation status, ALK rearrangement, KRAS, BRCA1/2, TMB, MSI-H/dMMR status); complete prior treatment history with documented responses and toxicities; and NCCN Clinical Practice Guidelines citation that is specific to your cancer type, staging, and molecular profile. "NCCN Guidelines for [Cancer Type], Version [X], Category 1 recommendation for patients with [exact molecular profile]." Category 1 NCCN recommendations reflect uniform consensus based on high-level evidence — if your treatment is Category 1 for your molecular profile, the denial is directly contrary to the recognized standard of care.

Step 3: Challenge Experimental Classification With NCCN Compendium

Under CMS rules, Medicare Advantage plans must cover anticancer chemotherapy uses recognized in the NCCN Drugs and Biologics Compendium. If your treatment is listed in the Compendium for your diagnosis and line of therapy, Humana is legally required under CMS regulations to cover it. For commercial plans, most states have oral chemotherapy parity laws and off-label use statutes requiring coverage of NCCN Compendium-listed uses.

Step 4: Invoke State Cancer Treatment Mandates

Many states mandate: (1) coverage for off-label cancer drug use when supported by recognized compendia; (2) oral chemotherapy parity — equal cost-sharing for oral and intravenous chemotherapy; (3) clinical trial participation; (4) access to specialized cancer centers. Cite the specific state statute applicable to your treatment type.

Step 5: Request Peer-to-Peer With an Oncologist Reviewer

Call Humana at 1-877-320-1235 and request a peer-to-peer between your oncologist and Humana's medical reviewer. Insist that the reviewer be a board-certified oncologist with expertise in your cancer type — under ACA regulations (45 C.F.R. § 147.136), the reviewer must have relevant specialty expertise. If the reviewer is not an oncologist, that is an independent procedural ground for overturning the denial.

Step 6: Escalate to External Independent Review: Complete Guide" class="auto-link">External Review or Medicare ALJ

For commercial plans, file for external review after internal denial. For Medicare Advantage: file with the Qualified Independent Contractor (Maximus Federal Services), then request an Administrative Law Judge hearing if needed. ALJ hearings have historically overturned Medicare denials at rates exceeding 70%.

What to Include in Your Appeal

• Denial letter with specific reason and Humana clinical coverage policy citation
• Oncologist's letter with complete cancer diagnosis, staging, molecular markers, treatment history, and NCCN guideline citation specific to cancer type, staging, and molecular profile
• NCCN Clinical Practice Guidelines excerpt: specific guideline, cancer type, evidence category (1, 2A, 2B, or 3)
• NCCN Compendium entry for your drug and indication (for off-label use or experimental classification challenge)
• Published peer-reviewed trial data from recognized journals (for experimental classification disputes)
• Documentation of treatment urgency with clinical consequences of delay stated in specific terms
• State cancer treatment mandate statute if applicable (oral chemo parity law, off-label use statute)

Fight Back With ClaimBack

A Humana cancer treatment denial demands immediate, aggressive action with NCCN guideline support, comprehensive oncologist documentation, expedited appeal rights, and — if needed — external review and regulatory complaints. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal